COMPANIES COVERED
Chipscreen BiosciencesDownload FREE Report Sample
Download Free sampleNatural killer cells are a type of cytotoxic lymphocyte, which is a component of the innate immune system.
Natural Killer Cell Therapeutics Market contains market size and forecasts of Natural Killer (NK) Cell Therapeutics in Global, including the following market information:
Global Natural Killer (NK) Cell Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Natural Killer (NK) Cell Therapeutics market was valued at 263.2 million in 2021 and is projected to reach US$ 1102.1 million by 2028, at a CAGR of 22.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Mogamulizumab Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Natural Killer (NK) Cell Therapeutics include Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb and NKT and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Natural Killer (NK) Cell Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Natural Killer (NK) Cell Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Natural Killer (NK) Cell Therapeutics Market Segment Percentages, by Type, 2021 (%)
Mogamulizumab
Lorvotuzumab Mertansine
Others
Global Natural Killer (NK) Cell Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Natural Killer (NK) Cell Therapeutics Market Segment Percentages, by Application, 2021 (%)
Cancer
Cardiovascular Diseases
Others
Global Natural Killer (NK) Cell Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Natural Killer (NK) Cell Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Natural Killer (NK) Cell Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Natural Killer (NK) Cell Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Chipscreen Biosciences
Affimed NV
Altor BioScience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest
Bristol-Myers Squibb
NKT
Henry Ford Health Services
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
